Literature DB >> 9107569

Sequential activation of alveolar macrophages by IFN-gamma and LPS is required for enhanced growth inhibition of virulent Mycobacterium bovis but not M. bovis BCG.

F E Aldwell1, D N Wedlock, B M Buddle.   

Abstract

Alveolar macrophages (AM) form the first line of defence against most respiratory pathogens and, unlike tissue macrophages, are constantly exposed to a wide variety of antigenic stimuli. In this study we investigated the in vitro effects of IFN-gamma and LPS on growth of virulent Mycobacterium bovis and M. bovis bacille Calmette-Guerin (BCG) in bovine AM. Bovine AM were purified from bronchial lavage fluid and cultured in serum-free medium. Pretreatment of bovine AM with IFN-gamma resulted in growth inhibition of M. bovis BCG but only partially inhibited growth of virulent M.bovis. Enhanced inhibition of virulent M.bovis by bovine AM required sequential stimulation with IFN-gamma and LPS and was associated with increased induction of nitric oxide (NO) and IL-12 mRNa. Growth inhibition of M. bovis was not affected by treatment of macrophages with the L-arginine analogue, NG-monomethyl-L-arginine although this treatment decreased NO production. These results suggest that a second activation signal in the form of TNF-alpha or LPS may be required to induce bacteriostasis of virulent M. bovis by bovine AM in vivo. The ability of bovine AM to respond to activation stimuli in vitro suggests that these cells may play an important role in preventing establishment of intracellular bacterial infections in the lung.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107569     DOI: 10.1038/icb.1997.22

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  6 in total

1.  Modeling the immune rheostat of macrophages in the lung in response to infection.

Authors:  Judy Day; Avner Friedman; Larry S Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

2.  Synthetic lipopeptide MALP-2 inhibits intracellular growth of Mycobacterium bovis BCG in alveolar macrophages-preliminary data.

Authors:  Grit Jörgens; Franz-Christoph Bange; Peter F Mühlradt; Reinhard Pabst; Ulrich A Maus; Thomas Tschernig
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

3.  Immunomodulatory effects of recombinant BCG expressing MSP-1C of Plasmodium falciparum on LPS- or LPS+IFN-γ-stimulated J774A.1 cells.

Authors:  Dhaniah Mohamad; Rapeah Suppian; Norazmi Mohd Nor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  In vitro T-cell activation of monocyte-derived macrophages by soluble messengers or cell-to-cell contact in bovine tuberculosis.

Authors:  E Liebana; A Aranaz; M Welsh; S D Neill; J M Pollock
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

5.  Mycobacterium bovis-infected cervine alveolar macrophages secrete lymphoreactive lipid antigens.

Authors:  F E Aldwell; B L Dicker; F M da Silva Tatley; M F Cross; S Liggett; C G Mackintosh; J F Griffin
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Immune responses induced in cattle by virulent and attenuated Mycobacterium bovis strains: correlation of delayed-type hypersensitivity with ability of strains to grow in macrophages.

Authors:  D N Wedlock; F E Aldwell; D M Collins; G W de Lisle; T Wilson; B M Buddle
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.